Skip to main content
Market intelligence
ROIVHealthcare

Roivant Sciences Ltd insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 24, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 24, 2026Eric VenkerPresident & Immunovant CEOSale200,000$33.16$6,631,260
May 22, 2026Eric VenkerPresident & Immunovant CEOSale200,000$30.27$6,054,000
Apr 20, 2026Eric VenkerPresident & Immunovant CEOSale200,000$29.59$5,918,000